Extract notice to the Minister

Banzel

Common name / Subject : Rufinamide
Name of the manufacturer : Eisai
Form : Comprimé
Dosage : 100 mg, 200 mg et 400 mg

Indication :

INESSS' Recommendation
Sous étude

Minister's decisions
Information actuellement non disponible en ligne

Evaluation published on June 01, 2012

Subscribe to our newsletter now

Subscription